Introduction: Who Should Undergo Diagnostics

Anyone who has undergone an allogeneic stem cell transplant—a procedure where stem cells from a donor are transplanted into a patient—should be monitored for chronic graft-versus-host disease. In this type of transplant, the donor’s cells are called the graft, and the patient who receives them is called the host. Sometimes, these donor cells mistakenly see the patient’s organs and tissues as foreign invaders and begin to attack them, leading to chronic graft-versus-host disease.^[1]

Most cases of chronic graft-versus-host disease develop within the first two years after transplant, though symptoms can appear at any time following the procedure. While healthcare providers once thought that chronic graft-versus-host disease only occurred after the first 100 days post-transplant, doctors now understand that timing alone doesn’t determine the type of the disease. Instead, they look at the specific symptoms and clinical signs to make an accurate diagnosis.^[1]

It’s particularly important for patients to seek diagnostic evaluation if they notice any unusual changes in their body after transplant. Because many people return home and have fewer check-ins with their transplant team as time goes on, self-monitoring becomes critically important. You should carefully inspect your mouth, eyes, skin, joints, and genital areas each week for any changes, no matter how small they seem. Don’t ignore subtle differences or assume they are nothing to worry about—reporting anything unusual to your doctor immediately is essential.^[3]

Certain patients have a higher risk of developing chronic graft-versus-host disease and should be especially vigilant about monitoring for symptoms. Those at increased risk include people who previously had acute graft-versus-host disease, older patients, those who received stem cells from an unrelated donor or a donor who was not a perfect match, and patients who were transplanted with stem cells collected from the bloodstream rather than bone marrow or cord blood. Men who received cells from female donors, particularly female donors who had previously been pregnant, also face higher risk.^[3]

Diagnostic Methods for Identifying Chronic Graft-Versus-Host Disease

Diagnosing chronic graft-versus-host disease can be challenging because its symptoms are often similar to those caused by other medical conditions, including certain autoimmune diseases where the body’s immune system mistakenly attacks healthy organs. Healthcare professionals must carefully evaluate each patient to ensure the symptoms are truly caused by chronic graft-versus-host disease and not something else.^[4]

The diagnostic process typically begins with a thorough physical examination. Your healthcare provider will examine your entire body, looking for visible signs of the disease. They will check your skin for rashes, texture changes, or thickening; inspect your mouth for white lines, sores, or difficulty opening your jaw; examine your eyes for dryness or irritation; and assess your joints and muscles for stiffness or reduced range of motion. They will also ask detailed questions about any symptoms you’ve been experiencing, such as shortness of breath, persistent cough, digestive problems, or changes in how your body functions.^[4]

Because chronic graft-versus-host disease can affect so many different organs and tissues throughout the body, your doctor may order various specialized tests to understand the full extent of the disease. The specific tests you need depend on which parts of your body are showing symptoms. For skin involvement, your doctor might perform a skin biopsy, where a small sample of skin tissue is removed and examined under a microscope to look for characteristic changes. This helps confirm the diagnosis and distinguish chronic graft-versus-host disease from other skin conditions.^[1]

If your eyes are affected—which commonly happens with chronic graft-versus-host disease—your doctor may refer you to an eye specialist who can perform specific eye examinations. These tests assess tear production, check for damage to the surface of the eye, and measure how well your eyes are functioning. Eye involvement in chronic graft-versus-host disease often causes a persistent dry or gritty feeling, blurred vision, or sensitivity to light.^[1]

When the liver is affected, blood tests become important diagnostic tools. Your healthcare provider will order liver function tests that measure specific enzymes and proteins in your blood. Elevated levels of certain enzymes can indicate that the liver is inflamed or damaged. Patients with liver involvement may also develop jaundice, a condition where the skin and whites of the eyes turn yellowish due to the buildup of a substance called bilirubin.^[1]

For patients experiencing digestive symptoms such as nausea, vomiting, or diarrhea, the doctor may need to examine the gastrointestinal tract more closely. This might involve procedures like endoscopy, where a thin, flexible tube with a camera is inserted through the mouth to view the esophagus, stomach, and upper intestine, or colonoscopy, where a similar tube is inserted through the rectum to examine the colon. During these procedures, the doctor can take small tissue samples (biopsies) to look for signs of chronic graft-versus-host disease.^[1]

Lung involvement requires different testing approaches. If you’re experiencing shortness of breath or a persistent dry cough, your doctor may order pulmonary function tests to measure how well your lungs are working. These tests involve breathing into a machine that measures the amount of air you can inhale and exhale and how quickly you can move air in and out of your lungs. Imaging tests such as chest X-rays or CT scans (computed tomography scans) may also be performed to create detailed pictures of your lungs and identify any abnormalities.^[1]

Mouth involvement is assessed through direct examination by your doctor or a dentist who specializes in transplant patients. They will look for painless white lines on your tongue or inner cheeks, mouth sores, gum disease, and difficulty opening your mouth fully. These symptoms can make eating, speaking, and maintaining oral hygiene difficult, so early detection and treatment are important.^[4]

When chronic graft-versus-host disease affects the muscles and joints, your doctor will test your range of motion and muscle strength. Joint involvement can cause stiffness, pain, and reduced mobility, which may be documented through physical examination and sometimes imaging studies. This helps distinguish chronic graft-versus-host disease from other conditions like arthritis that can cause similar symptoms.^[1]

Genital involvement requires sensitive examination and discussion with your healthcare provider. Women may experience vaginal dryness, itchiness, or pain during intercourse, while men may have itching or discomfort in the penis or scrotum. These symptoms can significantly affect quality of life and relationships, making proper diagnosis and treatment important.^[1]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments for chronic graft-versus-host disease. These studies help scientists and doctors discover better ways to manage this complex condition. To participate in a clinical trial, patients must meet specific criteria, which are determined through various diagnostic tests and assessments.^[5]

Before enrolling in a clinical trial for chronic graft-versus-host disease, extensive testing is typically required to establish baseline measurements and confirm that a patient is eligible. Researchers need to document exactly which organs are affected by the disease, how severe the involvement is, and whether previous treatments have been tried. This information helps ensure that the trial results are accurate and that the new treatment being tested is appropriate for each participant.^[7]

One of the most important aspects of clinical trial qualification is determining whether a patient has steroid-refractory chronic graft-versus-host disease. This term means that the disease has not responded adequately to treatment with corticosteroids (also called steroids), which are the standard first-line therapy. To establish this, doctors review the patient’s medical records to document previous steroid treatment and the response to it. Blood tests may be performed to check current levels of inflammation and organ function.^[9]

Clinical trials often require a thorough assessment of which organs are affected and the extent of involvement in each one. This typically involves many of the same diagnostic tests used for initial diagnosis, including biopsies, imaging studies, pulmonary function tests, and blood work. However, for research purposes, these tests may be performed more frequently and in more detail than in routine clinical care. The results are often scored using standardized rating scales that help researchers compare patients and track changes over time.^[7]

Quality of life assessments are also commonly used in clinical trials. These are questionnaires that ask patients detailed questions about how chronic graft-versus-host disease affects their daily activities, emotional well-being, physical functioning, and relationships. These assessments help researchers understand not just whether a treatment improves the disease medically, but whether it actually makes patients feel better and improves their ability to live normal lives.^[8]

Some clinical trials may have specific requirements regarding previous treatments. For example, a trial might only accept patients who have tried and failed at least one or two other therapies besides steroids. Your doctor will need to document your complete treatment history to determine if you meet these criteria. Other trials might exclude patients who have certain other health conditions or who are taking specific medications that could interfere with the experimental treatment being studied.^[9]

Before starting a clinical trial, patients typically undergo comprehensive laboratory testing to ensure they are healthy enough to participate safely. This includes blood tests to check blood cell counts, kidney function, liver function, and electrolyte levels. These baseline measurements are then compared to results obtained during the trial to monitor for any side effects or complications from the experimental treatment.^[7]

Throughout the clinical trial, participants undergo regular diagnostic testing to track how well the treatment is working. This might include repeated physical examinations, biopsies, imaging studies, blood tests, and quality of life questionnaires. The frequency and types of tests depend on the specific trial protocol. This close monitoring helps researchers gather the data needed to determine whether the new treatment is safe and effective, and it also helps ensure patient safety by detecting any problems early.^[9]